Corteva, Inc. CTVA
We take great care to ensure that the data presented and summarized in this overview for Corteva, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CTVA
View all-
Vanguard Group Inc Valley Forge, PA79.8MShares$5.99 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY53.7MShares$4.03 Billion0.07% of portfolio
-
State Street Corp Boston, MA34.2MShares$2.57 Billion0.09% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA22.6MShares$1.7 Billion2.99% of portfolio
-
Capital International Investors Los Angeles, CA20.9MShares$1.57 Billion0.27% of portfolio
-
Capital World Investors Los Angeles, CA19.3MShares$1.45 Billion0.21% of portfolio
-
Geode Capital Management, LLC Boston, MA17.8MShares$1.34 Billion0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA16.9MShares$1.27 Billion0.32% of portfolio
-
Independent Franchise Partners LLP London, X016.8MShares$1.26 Billion8.59% of portfolio
-
Harris Associates L P Chicago, IL13MShares$973 Million1.44% of portfolio
Latest Institutional Activity in CTVA
Top Purchases
Top Sells
About CTVA
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
Insider Transactions at CTVA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 13
2025
|
Cornel B Fuerer |
SELL
Open market or private sale
|
Direct |
55,242
-35.21%
|
$3,756,456
$68.06 P/Share
|
May 13
2025
|
Cornel B Fuerer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,242
+9.9%
|
$862,100
$50.7 P/Share
|
Apr 30
2025
|
Pat Ward |
BUY
Grant, award, or other acquisition
|
Direct |
2,990
+7.72%
|
-
|
Apr 30
2025
|
Michael O. Johanns |
BUY
Grant, award, or other acquisition
|
Direct |
2,990
+6.22%
|
-
|
Apr 30
2025
|
Marcos M Lutz |
BUY
Grant, award, or other acquisition
|
Direct |
2,990
+4.64%
|
-
|
Apr 30
2025
|
Nayaki R Nayyar |
BUY
Grant, award, or other acquisition
|
Direct |
3,514
+5.2%
|
$105,420
$31.0 P/Share
|
Apr 30
2025
|
Gregory R Page |
BUY
Grant, award, or other acquisition
|
Direct |
4,930
+7.08%
|
-
|
Apr 30
2025
|
Kerry J Preete |
BUY
Grant, award, or other acquisition
|
Direct |
2,990
+15.78%
|
-
|
Apr 30
2025
|
David C Everitt |
BUY
Grant, award, or other acquisition
|
Direct |
2,990
+14.79%
|
-
|
Apr 30
2025
|
Janet Plaut Giesselman |
BUY
Grant, award, or other acquisition
|
Direct |
3,052
+7.6%
|
$91,560
$31.0 P/Share
|
Apr 30
2025
|
Karen H. Grimes |
BUY
Grant, award, or other acquisition
|
Direct |
2,990
+15.87%
|
-
|
Apr 30
2025
|
Lamberto Andreotti |
BUY
Grant, award, or other acquisition
|
Direct |
2,990
+7.33%
|
-
|
Apr 30
2025
|
Klaus A Engel |
BUY
Grant, award, or other acquisition
|
Direct |
2,990
+7.19%
|
-
|
Apr 26
2025
|
Marcos M Lutz |
SELL
Payment of exercise price or tax liability
|
Direct |
941
-1.59%
|
$57,401
$61.47 P/Share
|
Apr 26
2025
|
Klaus A Engel |
SELL
Payment of exercise price or tax liability
|
Direct |
941
-2.58%
|
$57,401
$61.47 P/Share
|
Apr 04
2025
|
Robert D. King EVP, Crop Protection Business |
SELL
Payment of exercise price or tax liability
|
Direct |
9,398
-13.12%
|
$516,890
$55.79 P/Share
|
Apr 04
2025
|
Audrey Grimm SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
173
-0.83%
|
$9,515
$55.79 P/Share
|
Feb 28
2025
|
Brian Titus |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.93%
|
$6,572
$62.98 P/Share
|
Feb 28
2025
|
Cornel B Fuerer |
SELL
Payment of exercise price or tax liability
|
Direct |
540
-0.39%
|
$33,480
$62.98 P/Share
|
Feb 28
2025
|
Audrey Grimm SVP, Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
282
-1.34%
|
$17,484
$62.98 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 313K shares |
---|---|
Exercise of conversion of derivative security | 76.5K shares |
Payment of exercise price or tax liability | 90.9K shares |
---|---|
Open market or private sale | 166K shares |